Cadrenal Therapeutics Registers 2.9 Million Resale Shares Equal to 49% of Outstanding

The 424B3 prospectus covers shares tied to a pre-funded warrant and full-warrant PIPE placement with Armistice Capital, marking the company's fifth dilutive financing in three years.